GradedCalls Analysts
Loading the ledger…
GradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
AbbVie · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 1Y
—/100Average of active call grades
GC score—/10GC 1→GC 10
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
0
In this factor
Superseded
1
Visible, not scored
Hit rate
—
Active calls only
No graded calls for this horizon.
These calls count toward the overall factor once the horizon has a price. An open window is listed and is not in the average yet.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Michael YeeUBS | Target raise Desk rating stays Neutral | Hold | — | — | |||
| Oct 9, 2026 | Vamil DivanGuggenheim |
If followed
—
Active directional calls
No active graded calls in this window yet.
Desk rating stays Buy
| Buy |
| — |
| — |
| Oct 8, 2026 | Carter GouldCantor | Target raise Desk rating stays Overweight | Buy | — | — |
| Oct 7, 2026 Supersedes Supersedes prior call on Aug 3, 2026 (within 90 days). Prior call | Terence FlynnMorgan Stanley | Target raise Desk rating stays Overweight | Buy | — | — |
| Sep 10, 2026 | Rajesh KumarHSBC | Target raise Desk rating stays Buy | Buy | — | — |
| Aug 20, 2026 | David AmsellemPiper | Target raise Desk rating stays Overweight | Buy | — | — |
| Aug 17, 2026 | Mohit BansalWells Fargo | Target raise Desk rating stays Overweight | Buy | — | — |
| Aug 13, 2026 | Alexandria HammondWolfe | Upgrade to Outperform Desk rating Peer Perform → Outperform | Buy | — | — |
| Aug 11, 2026 | Navann TyBNP Paribas | Target raise Desk rating stays Neutral | Hold | — | — |
| Aug 10, 2026 | Gavin Clark-GartnerEvercore | Target raise Desk rating stays Outperform | Buy | — | — |
| Aug 3, 2026 | Gary NachmanCanaccord | Target raise Desk rating stays Buy | Buy | — | — |
| Jul 31, 2026 | Steve ScalaTD Cowen | Reiterate Buy Desk rating stays Buy | Buy | — | — |
History only. A later call on the same ticker within 90 days replaced these. The notes stay. They do not enter the overall factor.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 Nullified Nullified — superseded by later call on Oct 7, 2026 (within 90 days). Later call | Terence FlynnMorgan Stanley | Target raise Desk rating stays Overweight | Buy | — | — | Not scored |